journal club - mortality after fluid bolus in african children with severe infection - the feast...
DESCRIPTION
Critical Appraisal of: Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011;364:2483-95 Research in International Emergency Medicine: Scope, Impact and Challenges EBM Topic: Subgroup AnalysisTRANSCRIPT
![Page 1: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/1.jpg)
Journal ClubThe FEAST Trial: Mortality after Fluid Bolus in African Children with Severe Infection
Farooq Khan MDCMPGY-4 FRCP-EMMcGill University
August 22nd 2012
Salvatore Mottillo MDPGY-1 FRCP-EMMcGill University
![Page 2: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/2.jpg)
Objectives
• To critically appraise a high quality, high impact article conducted in a low-income country on a controversial topic in Emergency Medicine internationally
• To understand the importance of research and evidence-based medicine in low and middle income countries, in particular with respect to EM
• To appreciate the challenges of conducting research under austere conditions and how they can be overcome
![Page 3: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/3.jpg)
Outline
• Lecture on research in resource-poor settings• 1st half of FEAST trial video• Overview of the article• Appraisal• EBM topic: Subgroup analysis• 2nd half of video• Concluding remarks
![Page 4: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/4.jpg)
Research in International EMScope, Impact, and Challenges
Farooq Khan PGY4 FRCP-EM
![Page 5: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/5.jpg)
Outline
• Global Health Research on the WHO agenda– Why it is important– Challenges and how to overcome them– Example of its impact – TDR
• International EM research– Why it is important– Challenges and how to overcome them– Example of high-quality IEM research and its impact
![Page 6: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/6.jpg)
No Health Without Research
“It seems astonishing that in the 21st century decisions on health care can still be made without a solid grounding in research evidence. This is true even in clinical research, whether for simple or complex interventions1, where systematic reviews time and time again conclude that the evidence base is inadequate.2
It is even more true in the areas of health policy and health systems, where quality research is hampered further by a lack of shared definitions, a lack of consensus on guiding principles, poor capacity (especially in low-resource regions), and methodological challenges.3,4”
Pang T, Terry RF, The PLoS Medicine Editors (2011) WHO/PLoS Collection ‘‘No Health WithoutResearch’’: A Call for Papers. PLoS Med 8(1): e1001008. doi:10.1371/journal.pmed.1001008
![Page 7: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/7.jpg)
WHO – World Health Report 2013
• To show that research is important for meeting health needs and improving health outcomes
• To encourage countries to therefore invest more resources in developing and strengthening their national health research systems
• To argue that countries should not see research as an expense or as an afterthought, but as an investment for a better, healthier future
![Page 8: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/8.jpg)
WHO Research Policy
• Capacity• Priorities • Standards• Translation • Organization
WHO Research for Health Strategy - 63rd World Health Assembly May 2010
![Page 9: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/9.jpg)
TDR – At a glance - Video
• http://video.who.int/streaming/tdr/TDR_Gates_Award_video.wmv
![Page 10: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/10.jpg)
TDR – An example of the impact of global health research
• Take home messages– Ownership of research by communities
leads to faster translation into action in those countries
– Empowering countries to develop own priorities, own research capacities and own citizens to support healthcare systems leads to sustainable development
TDR at a glance: Fostering an effective global research effort on diseases of povertyWHO 2010
![Page 11: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/11.jpg)
EM Research in LMIC
“Emergency medical systems are part of the 10/90 gap in health research whereby less than 10% of global research investment is spent on problems affecting 90% of the world’s population”
Global Forum for Health Research. 10/90 report on health research 2002. Geneva: Global Forum for Health Research; 2002.
![Page 12: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/12.jpg)
EM Research in LMIC
• EM research from developed countries– May not be relevant to patients LMIC
• Variation in genetics, lifestyle and environment– May not be applicable to LMIC
• Variation in social, economic and political pressures– May not be easily translated into practice in LMIC
• Lack of resources for implementation, cultural barriers
V. Anantharaman. Scope of Emergency Medicine research in Low and Middle income CountriesEuSEM, AAEM, IV Mediterranean EM Congress 2007
![Page 13: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/13.jpg)
Emergency Care in LMIC
Challenges– Lack of pre-hospital care in
general– Scarcity of trained personnel at
all levels– Difficulty utilizing specialized
equipment– Weak telecommunications
infrastructure– Barriers in transportation– Health facilities lacking expertise – System lacking organization– Low levels of knowledge
translation
Interventions– Recruitment of lay responders– Training programs for nurses,
doctors and first responders– Equipment matched to level of
training– Harnessing cellular phone
technology and radio receiver sets
– Use of existing private motorized vehicles and bicycle transport
– Implementation of proper triage guidelines
– Organizing and financing system development
![Page 14: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/14.jpg)
Challenges faced by IEM researchers
• Time– High service demand
• Personnel– Lack of dedicated, trained researchers – Brain drain
• Finances– EDs are not profitable business units– Not prioritised by Pharma – Lack of government funding– High levels of indirect costs
– V. Anantharaman. Scope of Emergency Medicine research in Low and Middle income CountriesEuSEM, AAEM, IV Mediterranean EM Congress 2007
![Page 15: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/15.jpg)
Challenges faced by IEM researchers
• Infrastructure– Unreliable documentation – Basic data collection systems may be absent or
poorly implemented• Credibility
– Negative publication bias in HIC journals– Paucity of local journals in LMICs
![Page 16: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/16.jpg)
Challenges faced by IEM researchers
• Ethical issues– Lack of valid oversight bodies – Confidentiality– Informed consent– Cultural differences (researcher vs participants)– Double standards and exploitation of subjects
• Fly-in, fly-out research
Iserson et al Challenges in International Medicine:Ethical Dilemmas, Unanticipated Consequences, and Accepting Limitations, SAEM Journal 2012
Ford et al, Ethics of conducting research in conflict settings, Conflict and Health 2009, 3:7
![Page 17: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/17.jpg)
Strategies to circumvent challenges
• Capacity building on National/regional level– WHO, TDR, CIDA, etc.
• Capacity building on a local level– NGOs, University partnerships, leading by example
• Cost-saving endeavors– Better accountability, better prediction of direct
and indirect costs, recycling of costs saved, funding application strategies
![Page 18: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/18.jpg)
Strategies to circumvent challenges
• Ethical principles to follow– Independent external DSMB/IRB– Collaborative partnerships– Community engagement– Social value– Scientific validity– Fair selection of participants– Harm-benefit ratio– Respect for participants and consent
Ford et al, Ethics of conducting research in conflict settings, Conflict and Health 2009, 3:7
![Page 19: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/19.jpg)
Priority areas of research in LMIC
• Epidemiology of conditions that need to be addressed by emergency systems in these countries (e.g. trauma, infectious diseases)
• Economic analysis and cost-effectiveness in areas of low funding (e.g prehospital care, injury prevention)
• Well designed, locally appropriate intervention trials that establish effectiveness
![Page 20: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/20.jpg)
The FEAST Trial - Video
• http://www.youtube.com/watch?v=hK9VUkL-DqU
![Page 21: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/21.jpg)
The FEAST Trial
Overview
![Page 22: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/22.jpg)
Background
• Malaria, sepsis, & other infections associated with early mortality in African children
• Guidelines recommend fluid resuscitation for shock
• P.I.C.O. Question– In children presenting with severe febrile illness and
impaired perfusion, does administration of 20 ml boluses of 5% albumin solution or 0.9% saline solution per kg of body weight diminish mortality at 48 hours?
![Page 23: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/23.jpg)
Methods
• Article type– Sub-Saharan Africa, multicenter, open-treatment, RCT
• 2 stratum– Stratum A: children without severe hypotension (n=3,141)
• Group 1: saline-bolus group• Group 2: albumin-bolus group• Group 3: control group
– Stratum B: children with severe hypotension (n=29)• Same groups as A
• Initial boluses: 20 ml/kg
• Primary end-point– mortality at 48hrs
![Page 24: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/24.jpg)
Results
• Total patients: 3,170– Median age: 24mo.– Malaria: 57% of patients– Other parameters
• Mortality at 48hrs– Saline-bolus group: 10.5%– Albumin-bolus group: 10.6%– Control group: 7.3%
![Page 25: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/25.jpg)
Results
Mortality at 48 hours
![Page 26: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/26.jpg)
The FEAST Trial
Critical Appraisal
![Page 27: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/27.jpg)
Critical Appraisal
• Worksheet for a critical review of an article on therapy+
+Guyatt G, Rennie D, Meade M, Cook D. Users' Guides to the Medical Literature: essentials of Evidence-Based Clinical Practice. 2nd edition (Jama & Archives Journals). McGraw-Hill. Professional, 2008.
![Page 28: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/28.jpg)
Critical Appraisal
GROUP 1
• I. Are the results valid?
– 1. Were patients randomized?– 2. Was randomization concealed?– 3. Were patients in the study groups similar with respect
to known prognostic factors?– 4. To what extent was the study blinded?
![Page 29: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/29.jpg)
Critical Appraisal
GROUP 2
• I. Are the results valid? (continued)
– 5. Was follow-up complete?– 6. Were patients analyzed in the groups to which they
were randomized?– 7. Was the trial stopped early?
![Page 30: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/30.jpg)
Critical Appraisal
GROUP 3
• II. What are the results?
– 1. How large was the treatment effect?– 2. How precise was the treatment effect?– 3. Secondary endpoints studied?
![Page 31: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/31.jpg)
Critical Appraisal
GROUP 4
• III. How can I apply the results to my patient care?
– 1. Were all patient-important outcomes considered?– 2. Were the study patients similar to my patients?
![Page 32: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/32.jpg)
Critical Appraisal
Will the FEAST trial change your practice?
![Page 33: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/33.jpg)
Critical Appraisal - Answers
GROUP 1
• I. Are the results valid?– 1. Were patients randomized?
• Yes, Block randomization, stratified
– 2. Was randomization concealed?• Yes, Sealed envelopes, opened in numerical order
– 3. Were patients in the study groups similar with
respect to known prognostic factors?• Yes, large number of patients recruited (n=3,170)• Similar baseline characteristics between groups.
![Page 34: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/34.jpg)
Critical Appraisal - Answers
GROUP 1
![Page 35: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/35.jpg)
Critical Appraisal - Answers
GROUP 1
![Page 36: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/36.jpg)
Critical Appraisal - Answers
GROUP 1
![Page 37: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/37.jpg)
Critical Appraisal - Answers
GROUP 1
• I. Are the results valid?– 4. To what extent was the study blinded?
• Open-treatment trial
• Blinded end-point review committee
![Page 38: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/38.jpg)
Critical Appraisal
GROUP 2
• I. Are the results valid? (continued)– 5. Was follow-up complete?
• Few pts lost to f-u, and losses similar between groups– Saline-bolus group: 8/1047 pts lost to f-u by 48hrs– Albumin-bolus group: 7/1050 pts lost to f-u by 48hrs– Control group: 2/1044 pts lost to f-u by 48hrs
![Page 39: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/39.jpg)
Critical Appraisal
GROUP 2
• I. Are the results valid? (continued)– 6. Were patients analyzed in the groups to which they
were randomized?
• Almost all patients received intervention they were assigned to.– Saline-bolus group: 1041/1047 patients– Albumin-bolus group: 1045/1050 patients– Control group: 1043/1044 patients
• ITT analysis
![Page 40: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/40.jpg)
Critical Appraisal
GROUP 2
• I. Are the results valid? (continued)– 7. Was the trial stopped early?
• Yes, unlikely that superiority of the bolus strategy over the control strategy would be shown
![Page 41: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/41.jpg)
Critical Appraisal
GROUP 3
• II. What are the results?– 1. How large was the treatment effect?– 2. How precise was the treatment effect?– Mortality at 48 hours
• Saline-bolus group: 110 deaths /1047 patients (10.5%)– RR vs control: 1.44 (95% CI, 1.09 to 1.90)– ARI vs control: 3.22%– NNH vs control: 31.06– OR vs control: 1.50
![Page 42: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/42.jpg)
Critical Appraisal
GROUP 3
• II. What are the results?– Mortality at 48 hours
• Albumin-bolus group: 111/1050 (10.6%)– RR vs control: 1.45 (95% CI, 1.10 to 1.92)– ARI vs control: 3.29%– NNH vs control: 30.40– OR vs control: 1.51
![Page 43: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/43.jpg)
Critical Appraisal
GROUP 3
• II. What are the results?
– Mortality at 48 hours• Bolus therapy (saline + albumin groups)
– RR vs control: 1.45 (95% CI, 1.13 to 1.86)– ARI vs control: 3.26%– NNH vs control: 30.67– OR vs control: 1.50
• No bolus (control group): 76/1044 (7.3%)
![Page 44: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/44.jpg)
Critical Appraisal
GROUP 3
Mortality at 4 weeks
![Page 45: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/45.jpg)
Critical Appraisal
GROUP 3
![Page 46: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/46.jpg)
Critical Appraisal
GROUP 4
• III. How can I apply the results to my patient care?– 1. Were all patient-important outcomes considered?
• Yes, mortality at 48 hours– Secondary endpoints
» Mortality at 4 weeks» Pulmonary edema» Severe hypotension» Increased ICP» Neurologic sequelae
![Page 47: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/47.jpg)
Critical Appraisal
GROUP 4
• III. How can I apply the results to my patient care?– 1. Were the study patients similar to my patients?
• Inclusion criteria– Children b/w 60d and 12y of age– ‘Severe febrile illness’
![Page 48: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/48.jpg)
Critical Appraisal
GROUP 4
• III. How can I apply the results to my patient care?– 1. Were the study patients similar to my patients?
• Exclusion criteria– Severe malnutrition– Gastroenteritis– Non-infectious shock
![Page 49: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/49.jpg)
Critical Appraisal
GROUP 4
• III. How can I apply the results to my patient care?– Differences between the study pop. and my patients?
• Severe malnourishment» Pts with acute severe malnutrition excluded
• 2% (n=70) mid-upper-arm circumference of <11.5 cm.
![Page 50: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/50.jpg)
Critical Appraisal
GROUP 4
• III. How can I apply the results to my patient care?– Differences between the study pop. and my patients?
• High prevalence (57%) malaria» Subgroup: bolus vs no bolus in pts without malaria (n=1,330)
• RR death at 48 hrs: 1.43 (1.01-2.04)• Adjusted RR: 1.51 (1.17-1.94)
![Page 51: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/51.jpg)
Critical Appraisal
GROUP 4
• III. How can I apply the results to my patient care?– Differences between the study pop. and my patients?
• Severe anemia» Subgroup: bolus vs no bolus in pts with less severe anemia or
>5g/dl (n=1,384)
• RR death at 48 hrs: 1.31 (0.93-1.84)• Adjusted RR: 1.47 (1.14-1.90)
![Page 52: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/52.jpg)
Critical Appraisal
GROUP 4
• III. How can I apply the results to my patient care?– Differences between the study pop. and my patients?
• Pts did not fit WHO definition of shock» Subgroup: bolus vs no bolus in pts with WHO definition of
shock (n=65)
• ARI death at 48 hrs: 28.0 (3.4-52.5)
![Page 53: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/53.jpg)
The FEAST Trial
EBM Topic: Subgroup Analysis
![Page 54: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/54.jpg)
EBM topic: subgroup analysis
• Definition– Any evaluation of treatment effects for a specific endpoint
in subgroups of patients defined by baseline characteristics
• Why use subgroup analysis?– Differences in treatment effect between subpopulations– Consistency of trial conclusions for subpopulations
![Page 55: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/55.jpg)
EBM topic: subgroup analysis
• Evaluating variability in subgroup analyses– Visual evaluation of variability
• How similar are the point estimates?• To what extent to the confidence intervals overlap?
• Statistical tests evaluating variability– Yes-or-no tests for heterogeneity that generate P-value– I2 test that quantifies the variability explained by
differences in the results
• Be careful for possible confounders– Can be adjusted in multivariate analysis
![Page 56: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/56.jpg)
EBM topic: subgroup analysis
Subgroup analysis in the FEAST trial
![Page 57: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/57.jpg)
EBM topic: subgroup analysis
• Guidelines for Deciding Whether Apparent Differences in Subgroup Response Are Real+
– Did the hypothesis precede rather than follow the analysis?
– Was the subgroup difference one of a small number of hypothesized effects tested?
– Is the subgroup difference suggested by comparisons within rather than between studies?
+Guyatt G, Rennie D, Meade M, Cook D. Users' Guides to the Medical Literature: essentials of Evidence-Based Clinical Practice. 2nd edition (Jama & Archives Journals). McGraw-Hill. Professional, 2008.
![Page 58: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/58.jpg)
EBM topic: subgroup analysis
• Guidelines for Deciding Whether Apparent Differences in Subgroup Response Are Real
– Is the magnitude of the subgroup difference large?
– Is the subgroup difference consistent across studies?
– Was the subgroup difference statistically significant?
– Does external evidence support the
hypothesized subgroup difference?
![Page 59: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/59.jpg)
The FEAST Trial
Discussion & Conclusion
![Page 60: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/60.jpg)
Discussion
Will the FEAST trial change your practice?
![Page 61: Journal Club - Mortality after Fluid Bolus in African Children with Severe Infection - The FEAST Trial](https://reader035.vdocuments.us/reader035/viewer/2022062405/5564835ad8b42a73418b4777/html5/thumbnails/61.jpg)
Conclusion
• Fluid resuscitation increased the abs. risk of death at 48hrs by 3.3% in African hospitals
• Importance of fluid resuscitation as a lifesaving intervention in poor settings for children with shock?
• Questions raised regarding fluid-resuscitation guidelines in other settings as well